Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis
about
Can probiotics benefit children with autism spectrum disorders?Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.Health benefits observed after probiotic Lactobacillus fermentum CCM 7421 application in dogs.The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome.Lactobacillus gasseri attenuates allergic airway inflammation through PPARγ activation in dendritic cells.[Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.Microscopic colitis-microbiome, barrier function and associated diseases.Bifidobacterium infantis 35624 and other probiotics in the management of irritable bowel syndrome. Strain specificity, symptoms, and mechanisms.A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies.Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.Fecal Microbiota Transplantation Is Effective in Relieving Visceral Hypersensitivity in a Postinfectious Model.Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin
P2860
Q28076833-19AC7589-71EC-405D-B4E6-FDF4ACCCFE1FQ33786003-20AD8FDA-F957-4534-BC0A-9E5380FF4E91Q38921708-828A6AAD-CEFD-438B-AD35-55BEBEFB8B78Q39443205-4D0FC9FA-21DE-45F3-8349-7D51CE8BD279Q49653059-E1B7CCDE-6B54-4E29-94EB-B296762E21FBQ50069975-6A13533D-D897-43D6-B9B5-D0F1E318E15BQ50075647-E695F24D-D112-4538-9CC6-9F3A27E33D46Q50300062-C7D92823-AC42-451D-9615-469838ECA34EQ52333906-35CC1C14-8C10-4536-823D-5F848D45044DQ53728716-0D637BB3-EC71-4BEF-AF93-408991E2952BQ54263480-80CDCA88-21A7-48D7-972F-4E27D8B76613Q55023884-BE21FDCF-262D-447F-9D06-6ACD0F43252AQ55063629-7ABAA86C-BF9A-468E-ACD3-3D449C9E4662Q55517435-46767089-62BC-4767-B76B-D3F9ADA1F4DFQ57070200-DE80CEDB-B697-420D-A866-D929DCDB453E
P2860
Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effects of probiotic type, dos ...... III criteria: a meta-analysis
@ast
Effects of probiotic type, dos ...... III criteria: a meta-analysis
@en
type
label
Effects of probiotic type, dos ...... III criteria: a meta-analysis
@ast
Effects of probiotic type, dos ...... III criteria: a meta-analysis
@en
prefLabel
Effects of probiotic type, dos ...... III criteria: a meta-analysis
@ast
Effects of probiotic type, dos ...... III criteria: a meta-analysis
@en
P2093
P2860
P1433
P1476
Effects of probiotic type, dos ...... III criteria: a meta-analysis
@en
P2093
Bingcheng Feng
Chuanguo Guo
Lixiang Li
Yanqing Li
P2860
P2888
P356
10.1186/S12876-016-0470-Z
P577
2016-06-13T00:00:00Z
P6179
1035960567